BioMarin to Present at Multiple Investor Conferences in September
BioMarin Pharmaceutical Inc., a global leader in rare disease biotechnology, announced that its management team will present at four investor conferences scheduled for late September 2026. The events include the Wells Fargo Healthcare Conference on September 9 and three additional conferences from September 10 to 14. Live audio webcasts of these presentations will be available via BioMarin's website, with archived versions accessible afterward. BioMarin is known for its focus on genetically defined conditions and has nine commercial therapies currently in use. The company emphasizes innovation through a distinctive approach to drug discovery and development aimed at creating impactful treatments for rare diseases.
Tickers: $BMRN
Topics: investor_relations pharmaceutical